Obalon Therapeutics Inc (OBLN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | OBLN | TMO | ISRG | EW | IDXX |
| Company | Obalon Therapeutics Inc | Thermo Fisher Scientific Inc | Intuitive Surg Inc | Edwards Lifesciences Corp | Idexx Laboratories |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NYSE | NASDAQ |
| Open | 9.75 | 542.95 | 385.27 | 87.20 | 482.20 |
| High | 14.40 | 546.14 | 388.65 | 87.20 | 482.21 |
| Low | 8.84 | 539.17 | 364.17 | 85.38 | 471.42 |
| Last | 9.15 | 544.78 | 366.34 | 85.94 | 476.35 |
| Change | -0.57 | +3.26 | -6.29 | -0.51 | -1.44 |
| % Change | -5.86% | +0.60% | -1.69% | -0.59% | -0.30% |
| Volume | 8,927,233 | 1,738,500 | 3,975,800 | 3,895,700 | 568,600 |
| 20-Day Average Volume | 7,631,245 | 1,286,730 | 1,598,140 | 3,021,250 | 405,345 |
| Previous Close | 9.72 | 541.52 | 372.63 | 86.45 | 477.79 |
| Industry | Medical Instruments | Medical Instruments | Medical Instruments | Medical Instruments | Medical Instruments |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 3.23 | 569.43 | 386.15 | 91.70 | 511.95 |
| 20-Day Raw Stochastic | 27.38% | 25.11% | 5.48% | 5.21% | 6.86% |
| 20-Day Relative Strength | 49.61% | 39.07% | 39.78% | 41.27% | 27.23% |
| Weighted Alpha | -38.05 | -1.46 | +22.64 | +4.34 | -6.32 |
| Today's Opinion | 40% Buy | 24% Buy | 40% Buy | 56% Buy | 24% Sell |
| Previous Opinion | 56% Buy | 40% Buy | 56% Buy | 56% Buy | 24% Sell |
| Last Month's Opinion | 16% Sell | 88% Buy | 100% Buy | 88% Buy | 56% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -8.68% since 06/08/21 | -3.62% since 04/12/24 | -4.80% since 04/12/24 | -4.81% since 04/12/24 | -4.31% since 04/12/24 |
| Low | 2.95 on 06/15/21 | 529.64 on 04/18/24 | 364.17 on 04/19/24 | 85.38 on 04/19/24 | 471.42 on 04/19/24 |
| High | 4.80 on 06/15/21 | 570.72 on 04/15/24 | 392.29 on 04/15/24 | 91.73 on 04/15/24 | 506.57 on 04/15/24 |
| 1-Month | |||||
| %Chg | +27.62% since 05/14/21 | -6.51% since 03/19/24 | -6.19% since 03/19/24 | -8.87% since 03/19/24 | -10.87% since 03/19/24 |
| Low | 2.26 on 05/17/21 | 529.64 on 04/18/24 | 364.17 on 04/19/24 | 85.38 on 04/19/24 | 471.42 on 04/19/24 |
| High | 4.88 on 05/24/21 | 589.93 on 04/09/24 | 403.76 on 03/27/24 | 96.12 on 03/28/24 | 543.33 on 03/28/24 |
| 3-Month | |||||
| %Chg | -16.67% since 03/15/21 | -1.26% since 01/19/24 | -2.26% since 01/19/24 | +15.65% since 01/19/24 | -9.06% since 01/19/24 |
| Low | 1.95 on 05/06/21 | 529.64 on 04/18/24 | 362.14 on 01/24/24 | 71.92 on 01/25/24 | 471.42 on 04/19/24 |
| High | 4.88 on 05/24/21 | 603.82 on 03/08/24 | 403.76 on 03/27/24 | 96.12 on 03/28/24 | 583.39 on 03/01/24 |
| 6-Month | |||||
| %Chg | +98.03% since 12/15/20 | +15.99% since 10/19/23 | +33.97% since 10/19/23 | +24.41% since 10/19/23 | +11.90% since 10/19/23 |
| Low | 1.38 on 01/06/21 | 415.60 on 10/25/23 | 254.85 on 10/30/23 | 60.57 on 10/30/23 | 372.50 on 11/01/23 |
| High | 10.77 on 01/20/21 | 603.82 on 03/08/24 | 403.76 on 03/27/24 | 96.12 on 03/28/24 | 583.39 on 03/01/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 30,567 | 206,705,760 | 132,078,328 | 52,036,584 | 39,682,372 |
| Shares Outstanding, K | 10,022 | 381,714 | 354,449 | 601,927 | 83,054 |
| Annual Sales | 1,590,000 | 42,857,000,000 | 7,124,100,000 | 6,004,800,000 | 3,660,950,000 |
| Annual Net Income | -12,330,000 | 5,995,000,000 | 1,798,000,000 | 1,402,400,000 | 845,040,000 |
| Last Quarter Sales | 60,000 | 10,886,000,000 | 1,928,300,000 | 1,534,100,000 | 901,600,000 |
| Last Quarter Net Income | -1,320,000 | 1,630,000,000 | 606,200,000 | 369,900,000 | 194,520,000 |
| 60-Month Beta | -1.23 | 0.80 | 1.36 | 1.05 | 1.26 |
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 5.67 on 01/31/24 | 1.50 on 04/18/24 | 0.64 on 02/06/24 | 2.32 on 02/05/24 |
| Latest Earnings Date | 07/29/21 | 04/24/24 | 04/18/24 | 04/25/24 | 05/01/24 |
| Most Recent Dividend | N/A | 0.390 on 03/14/24 | N/A | N/A | N/A |
| Next Ex-Dividends Date | N/A | 03/14/24 | N/A | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 25.41 | 82.78 | 34.76 | 47.49 |